Medtronic

This study is observing how well a special feature in heart devices works to control dangerously fast heart rhythms. The feature tries to stop these rhythms with gentle electrical pulses instead of painful shocks. Researchers are following 2,200 patients who already have these de…

This study is tracking the long-term safety and performance of the Micra wireless pacemaker in real-world patients. It will follow 3,100 people who receive the device for at least 9 years to monitor for any complications and see how well it works over time. The goal is to confirm…

This study is monitoring the long-term safety and performance of a specific heart defibrillator lead (the OmniaSecure™) after it has been approved for sale. It will follow 2,000 patients who have this device implanted to treat dangerously fast heart rhythms. Researchers will trac…

This study is checking how well a special feature in some heart devices works in everyday life. The feature tries to warn doctors when a heart failure patient is at high risk of getting sicker. Researchers are watching 2,200 patients with these devices to see if the warnings are …

This study is monitoring the long-term safety of a drug-coated balloon used to open blocked or narrowed blood vessels in dialysis access fistulas in the arm. It will follow 240 patients for five years to check for serious infections and other safety issues. The study is required …

This study is monitoring the long-term safety and performance of a specific heart device lead (Model 4798) in over 1,000 patients with heart failure. It's a required follow-up study by the FDA after the device's initial approval. Researchers are tracking patients for five years t…

This study aims to gather real-world evidence on the safety and effectiveness of the Micra leadless pacemaker, a small device implanted in the heart to treat slow heart rhythms. It will analyze the health insurance claims of 37,000 Medicare patients to track complication rates an…

This study aims to collect real-world safety and effectiveness data on the Micra AV, a small, leadless pacemaker, as required by Medicare. It will analyze the health insurance claims of 37,000 Medicare patients who received either the Micra AV or a traditional pacemaker. The main…